NOV 13, 2019 9:31 AM PST

Sherlock's DNA biosensors set to make diagnostics elementary

WRITTEN BY: Tara Fernandez

Waiting anxiously to receive results from expensive diagnostic laboratory tests could soon be a thing of the past thanks to a technological breakthrough. Engineering start-up Sherlock Biosciences, in collaboration with UK diagnostics company Mologic, recently announced they are joining forces to develop sophisticated molecular diagnostic devices simple enough for anyone to use - all from the comfort of home.

Backed by funding from the Bill & Melinda Gates Foundation, this new venture aims to blend Sherlock’s proprietary synthetic biology-based platform with Mologic’s lateral flow immunoassays. The result? Easy-to-use diagnostic devices, completely bypassing the need for complicated instrumentation and expert technicians.

Lateral flow technology is already widely used for point-of-care testing, with the most common example being pregnancy test sticks. Biological samples applied to the device get drawn up through a membrane and flow over antibodies. Interactions between the sensor and a biological marker present in the sample trigger a color change that acts as a visual cue, indicating a positive or negative result. 

The difference with Mologic’s platform is that it’s exceptionally sensitive, low-cost, has a clear visual readout and can potentially be applied to many infectious diseases, for which diagnosis is at present, a complicated affair.

The strategy of this collaboration is to amplify these diagnostic capabilities by coupling them with INSPECTR™, Sherlock’s synthetic DNA biosensor platform. INSPECTR™ (an acronym for Internal Splint-Pairing Expression Cassette Translation Reaction) is the result of research performed by Sherlock’s co-founders at Harvard University. Biosensors in INSPECTR™ can detect minute amounts of a target nucleic acid sequence in blood, saliva or urine. This drives the production of a reporter protein, which can be tailored to create a signature visual signal - a colored indicator or a fluorescent glow, for example.

Speaking on the significance of this development, co-founder, CEO and President of Sherlock, Rahul K. Dhanda said, “This program will enable us to build on the power of our INSPECTR platform to create diagnostic tools that provide accurate and affordable results in virtually any setting, while working with Mologic and the Bill & Melinda Gates Foundation to develop lateral flow technology to improve global health.”

Sources: Technology Networks, Sherlock Biosciences

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
OCT 05, 2020
Microbiology
Deadly Microbe Linked to Childhood Brain Disorder
OCT 05, 2020
Deadly Microbe Linked to Childhood Brain Disorder
Pediatric hydrocephalus - excessive fluid on the brain of a child - has been connected to a bacterial pathogen.
OCT 15, 2020
Microbiology
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
OCT 15, 2020
WHO Data Suggests Remdesivir Has No Effect on COVID-19 Infections
While the study has not yet been peer-reviewed, an International consortium including researchers has come to the conclu ...
OCT 19, 2020
Cancer
Using qPCR to Diagnose Common Cancer Mutations in Lung Cancer
OCT 19, 2020
Using qPCR to Diagnose Common Cancer Mutations in Lung Cancer
Cancer is a disease characterized by DNA mutations. These mutations, while sometimes small, can cause havoc in a cell&rs ...
OCT 21, 2020
Cell & Molecular Biology
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
OCT 21, 2020
Extracellular Vesicles Help Heart Cells Survive a Heart Attack
During a heart attack, blood flow is blocked and cells lose oxygen and begin to die. Scientists are developing many new ...
OCT 24, 2020
Genetics & Genomics
Cord Blood Samples Reveal More About the Genetics of Autism
OCT 24, 2020
Cord Blood Samples Reveal More About the Genetics of Autism
The activity of genes in our genome is controlled by many factors, one of which are chemical tags or structural changes ...
OCT 25, 2020
Health & Medicine
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
OCT 25, 2020
Over 4 in 10 People With MS Have Used Cannabis in the Last Year
University of Michigan researchers have found that Americans with Multiple sclerosis (MS) are twice as likely as the gen ...
Loading Comments...